Folic acid and Zejula drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Folic acid (folic acid) and Zejula (niraparib tosylate). Common drug interactions include platelet count decreased among females.

The phase IV clinical study analyzes what interactions people have when they take Folic acid and Zejula. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Folic acid?

Folic acid has active ingredients of folic acid. It is often used in rheumatoid arthritis. eHealthMe is studying from 165,027 Folic acid users. Check the latest studies of Folic acid.

What is Zejula?

Zejula has active ingredients of niraparib tosylate. eHealthMe is studying from 22,014 Zejula users. Check the latest studies of Zejula.

On Jul, 31, 2026

37 people who take Folic acid and Zejula together, and have interactions are studied.

Folic acid and Zejula drug interactions.

What are the common drug interactions of Folic Acid and Zejula, by gender? *:

female:

Platelet count decreased
Fatigue (feeling of tiredness)
Headache (pain in head)
Dry skin
Haematocrit decreased
Osteopenia (a condition where bone mineral density is lower than normal)
Pruritus (severe itching of the skin)
Thrombocytopenia (decrease of platelets in blood)
Urinary tract infection
Urticaria (rash of round, red welts on the skin that itch intensely)

male:

n/a

What are the common drug interactions of Folic Acid and Zejula, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood pressure decreased
Blood pressure fluctuation
Constipation
Decreased activity
Decreased appetite
Dizziness
Gait disturbance
Headache (pain in head)
Heart rate irregular
Nausea (feeling of having an urge to vomit)

60+:

Platelet count decreased
Fatigue (feeling of tiredness)
Constipation
Dehydration (dryness resulting from the removal of water)
Lymphocyte count decreased
Mean cell haemoglobin increased (more than normal haemoglobin per red blood cell in a sample of blood)
Mean cell volume increased (more than normal average red blood cell volume)
Mouth ulceration (mouth ulcers)
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 24 people, 64.86%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 14 people, 37.84%
Fallopian Tube Cancer (cancer of fallopian tube): 5 people, 13.51%
Nausea And Vomiting: 4 people, 10.81%
Nausea (feeling of having an urge to vomit): 4 people, 10.81%
High Blood Pressure: 4 people, 10.81%
Endometrial Cancer: 4 people, 10.81%
Retroperitoneal Cancer (cancer between the peritoneum and the posterior abdominal wall): 2 people, 5.41%
Ovarian Epithelial Cancer Recurrent (reoccurrence of cancer that begins in the cells on the surface of the ovary): 2 people, 5.41%
Ovarian Epithelial Cancer (cancer that begins in the cells on the surface of the ovary): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Folic acid and Zejula?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously